Nuveen’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Nuveen’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-331,621	Closed	-$9.13M	–	3466
2021 Q2	$9.13M	Sell	331,621 -211,028	-39%	-$4.15M	﹤0.01%	1924
2021 Q1	$8.95M	Sell	542,649 -2,286	-0.4%	-$52.1K	﹤0.01%	1864
2020 Q4	$10M	Sell	544,935 -10,836	-2%	-$194K	﹤0.01%	1710
2020 Q3	$7.56M	Buy	555,771 +339,961	+158%	+$5.24M	﹤0.01%	1691
2020 Q2	$3.87M	Buy	215,810 +77,288	+56%	+$1.17M	﹤0.01%	2042
2020 Q1	$1.38M	Buy	138,522 +20,855	+18%	+$171K	﹤0.01%	2368
2019 Q4	$958K	Sell	117,667 -335	-0.3%	-$3.09K	﹤0.01%	2701
2019 Q3	$1.17M	Buy	118,002 +858	+0.7%	+$8.1K	﹤0.01%	2631
2019 Q2	$1.48M	Buy	+117,144	New	+$1.23M	﹤0.01%	2574

Nuveen's TBIO Position: Q3 2021 in Review

Nuveen sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 331,621 shares — an estimated $9.13M sold.

Nuveen first reported a position in TBIO in Q2 2019 and held it in 9 quarters. The position peaked at $10M in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Nuveen reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Nuveen sold 331,621 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $9.13M.
Nuveen first reported a position in Translate Bio, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
Nuveen's Translate Bio, Inc. Common Stock position peaked at $10M in Q4 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.